文献速递胸部CT

能谱CT参数对非小细胞肺癌EGFR基因突变的预测价值

Predictive value of spectral computed tomography parameters for EGFR gene mutation in non-small-cell lung cancer.
PubMed 文献 · Clin Radiol · 2024-05-04

回顾性纳入新疆医科大学附属肿瘤医院2017年1月至2019年12月的中晚期非小细胞肺癌患者79例,比较EGFR突变阳性组(32例)与阴性组(47例)的形态学征象和能谱CT定量参数,多因素分析显示肺内转移、远处转移、静脉期NIC、静脉期λ和病理分期为独立预测因素,AUC为0.975。

要点

  • 静脉期NIC和静脉期能谱曲线斜率λ是预测EGFR突变的独立能谱CT定量参数。
  • 肺内转移、远处转移和病理分期也是预测EGFR突变的独立因素。
  • 联合上述指标的AUC为0.975,敏感度91.5%,特异度90.6%。

核心结论

  • 病理分期及能谱CT参数中的肺内转移、远处转移、静脉期NIC和静脉期λ可能在本前预测中晚期非小细胞肺癌的EGFR基因突变。

研究设计与样本

  • 回顾性观察性研究,纳入新疆医科大学附属肿瘤医院2017年1月至2019年12月中晚期非小细胞肺癌患者79例,分为EGFR突变阳性组(32例)和阴性组(47例),比较形态学征象与能谱CT定量参数。

关键影像表现/征象

  • EGFR突变阳性组与阴性组在分叶征、肺内转移、纵隔淋巴结转移、远处转移、骨转移方面差异有统计学意义(P<0.001)。
  • EGFR突变阳性组与阴性组在动脉期NIC(P=0.001)、静脉期NIC(P=0.001)、能谱曲线斜率λ(P<0.001)方面差异有统计学意义。
  • EGFR突变阳性组与阴性组在动脉期70 keV CT值(P=0.004)和静脉期70 keV CT值(P=0.003)方面差异有统计学意义。

诊断标准与关键数值

  • 多因素logistic回归显示肺内转移、远处转移、静脉期NIC、静脉期λ和病理分期为预测EGFR基因突变的独立因素。
  • 联合上述独立因素预测EGFR基因突变的AUC为0.975,敏感度91.5%,特异度90.6%。

临床应用与阅片要点

  • 原文结论认为病理分期及能谱CT参数肺内转移、远处转移、静脉期NIC和静脉期λ可能在本前预测中晚期非小细胞肺癌EGFR基因突变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To explore the predictive value of morphological signs and quantitative parameters from spectral CT for EGFR gene mutations in intermediate and advanced non-small-cell lung cancer (NSCLC).

MATERIALS AND METHODS: This retrospective observational study included patients with intermediate or advanced NSCLC at Xinjiang Medical University Affiliated Tumor Hospital between January 2017 and December 2019. The patients were divided into the EGFR gene mutation-positive and -negative groups.

RESULTS: Seventy-nine patients aged 60.75 ± 9.66 years old were included: 32 were EGFR mutation-positive, and 47 were negative. There were significant differences in pathological stage (P<0.001), tumor diameter (P=0.019), lobulation sign, intrapulmonary metastasis, mediastinal lymph node metastasis, distant metastasis (P<0.001), bone metastasis (P<0.001), arterial phase normalized iodine concentration (NIC) (P=0.001), venous phase NIC (P=0.001), slope of the energy spectrum curve (λ) (P<0.001), and CT value at 70 keV in arterial phase (P=0.004) and venous phase (P=0.003) between the EGFR mutation-positive and -negative patients. The multivariable logistic regression analysis showed that intrapulmonary metastasis, distant metastasis, venous phase NIC, venous phase λ, and pathological stage were independent factors predicting EGFR gene mutations, with high diagnostic power (AUC = 0.975, 91.5% sensitivity, and 90.6% specificity).

CONCLUSION: The pathological stage and the spectral CT parameters of intrapulmonary metastasis, distant metastasis, venous phase NIC, and venous phase λ might pre-operatively predict EGFR gene mutations in intermediate and advanced NSCLC.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Yu Y, Han C, Gan X, et al. Predictive value of spectral computed tomography parameters for EGFR gene mutation in non-small-cell lung cancer. Clin Radiol. 2024. PMID: 38797609. doi:10.1016/j.crad.2024.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。